ES2048263T3 - Composicion liofilizada de mdm y metodo para su fabricacion. - Google Patents

Composicion liofilizada de mdm y metodo para su fabricacion.

Info

Publication number
ES2048263T3
ES2048263T3 ES89119819T ES89119819T ES2048263T3 ES 2048263 T3 ES2048263 T3 ES 2048263T3 ES 89119819 T ES89119819 T ES 89119819T ES 89119819 T ES89119819 T ES 89119819T ES 2048263 T3 ES2048263 T3 ES 2048263T3
Authority
ES
Spain
Prior art keywords
solution
acid
lyophilized
mdm
bencilpenylloic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89119819T
Other languages
English (en)
Inventor
Sudhakar S Dr Wagle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma GmbH
Original Assignee
Schwarz Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schwarz Pharma AG filed Critical Schwarz Pharma AG
Application granted granted Critical
Publication of ES2048263T3 publication Critical patent/ES2048263T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9446Antibacterials

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

UNA COMPOSICION (MDM) MEZCLA DETERMINANTE MENOR LIOFILIZADA, ESTABLE DE ALMACENAJE QUE PUEDEN SER RECONSTITUIDAS CON AGUA PARA PRODUCIR UNA SOLUCION QUE ES USADA PARA DETECTAR ALERGIAS O HIPERSENSIBILIDADES A PENICILINAS, COMPRENDEN: ACIDO BENCILPENILOICO; BENCILPENICILIN; ACIDO BENCILPENICILOICO EN DONDE AL MENOS SOBRE EL 94.5 % DEL ACIDO BENCILPENICILOICO ES EL ESTEROISOMERO (5R,6R)-BENCIL-D-ACIDO PENICILOICO; UNA SAL DE METAL ALCALI; UNA SUSTANCIA AMORTIGUADORA DE PH; Y UNA CANTIDAD BAJA CRITICAMENTE DE AGUA. EN EL METODO DEL INVENTO, ES PREPARADA UNA SOLUCION ACUOSA DE ACIDO BENCILPENILOICO, UNA SAL DE METAL ALCALI, Y UNA SUSTANCIA AMORTIGUADORA DE PH. EL ACIDO BENCILPENILOICO EN ESTA SOLUCION ES NEUTRALIZADA CON HIDROXIDO DE SODIO ACUOSO. MIENTRAS MANTENIENDO ESTA SOLUCION A UNA TEMPERATURA DESDE SOBRE 0 C A SOBRE 5 C, LOS SIGUIENTES PASOS SON REPRESENTADOS : PRIMERO, LOS ACIDOS BENCILPENICILIN Y EL BENCILPENICILOICO SON DISUELTOS DENTRO DE LA SOLUCION. EL ACIDO BENCILPENICILOICO EN LA SOLUCION ES NEUTRALIZADO CON HIDROXIDO DE SODIO ACUOSO. SIGUIENTE, EL PH DE LA SOLUCION ES AJUSTADO A UN PH FISIOLOGICO. ESTA SOLUCION ES ENTONCES FILTRADA ESTERIL. DESPUES DE REPRESENTAR ESOS PASOS EN EL QUE LA SOLUCION ES MANTENIDA A UNA TEMPERATURA DESDE SOBRE 0 C A SOBRE 5 C, LA SOLUCION ES CONGELADA EN CONTENEDORES DESHIDRATADOS. DESPUES DE CONGELAR, LA SOLUCION CONGELADA ES LIOFILIZADA.
ES89119819T 1988-11-01 1989-10-25 Composicion liofilizada de mdm y metodo para su fabricacion. Expired - Lifetime ES2048263T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26574988A 1988-11-01 1988-11-01

Publications (1)

Publication Number Publication Date
ES2048263T3 true ES2048263T3 (es) 1994-03-16

Family

ID=23011751

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89119819T Expired - Lifetime ES2048263T3 (es) 1988-11-01 1989-10-25 Composicion liofilizada de mdm y metodo para su fabricacion.

Country Status (7)

Country Link
EP (1) EP0367090B1 (es)
AT (1) ATE100210T1 (es)
DE (1) DE68912270T2 (es)
DK (1) DK542089A (es)
ES (1) ES2048263T3 (es)
IE (1) IE60788B1 (es)
PT (1) PT92163B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT1588U1 (de) * 1994-04-27 1997-08-25 Mahl Christian Dr Verfahren zur herstellung von testsubstanzen für verfahren mit erfassung elektromagnetischer schwingungen
EP3087991A1 (en) * 2003-11-08 2016-11-02 Prothera Biologics Composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
EP2291654B1 (en) 2008-05-28 2018-04-11 Prothera Biologics, Inc. Preparation and composition of inter-alpha inhibitor proteins from blood
US9572872B2 (en) 2012-09-09 2017-02-21 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
MX2015009141A (es) 2013-01-15 2016-03-16 Teva Pharma Formulaciones de albu-bche, preparacion y usos de las mismas.
CA2897062A1 (en) * 2013-01-15 2014-07-24 Teva Pharmaceutical Industries Ltd. Lyophilization process
CN106187934A (zh) * 2016-07-08 2016-12-07 上海上药新亚药业有限公司 一种羧苄西林钠杂质g的合成方法
EP3512539A4 (en) 2016-09-13 2020-07-29 Prothera Biologics, Inc. METHODS FOR TREATING LUNG DISEASE USING INTER-ALPHA INHIBITOR PROTEINS
CA3061164A1 (en) 2017-04-25 2018-11-01 Prothera Biologics, Inc. Methods for quantifying inter-alpha inhibitor proteins
US20180326095A1 (en) * 2017-05-11 2018-11-15 AllerQuest LLC Kits and methods to detect penicillin allergy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316882A (en) * 1978-04-20 1982-02-23 Levine Bernard B Compositions for testing to predict and/or diagnose allergy to penicillins
US4183910A (en) * 1978-04-20 1980-01-15 Levine Bernard B Method for testing to predict and/or diagnose allergy to penicillins, and compounds and compositions for use in such tests
JPS63174927A (ja) * 1987-01-14 1988-07-19 Tanabe Seiyaku Co Ltd 抗菌性凍結乾燥製剤

Also Published As

Publication number Publication date
DE68912270T2 (de) 1994-04-28
IE893397L (en) 1990-05-01
ATE100210T1 (de) 1994-01-15
PT92163A (pt) 1990-05-31
PT92163B (pt) 1995-07-18
EP0367090B1 (en) 1994-01-12
DE68912270D1 (de) 1994-02-24
DK542089D0 (da) 1989-10-31
DK542089A (da) 1990-05-02
IE60788B1 (en) 1994-08-10
EP0367090A1 (en) 1990-05-09

Similar Documents

Publication Publication Date Title
US4980277A (en) Cryoprotectant solution and method
ES2048263T3 (es) Composicion liofilizada de mdm y metodo para su fabricacion.
ES2075623T3 (es) Productos de bebida que contienen leche, estables en almacenamiento.
KR900007427A (ko) 안과용 수용액제 및 이를 보존하는 방법
ATE76288T1 (de) Feste pharmaceutische zubereitung mit verlaengerter wirkstofffreigabe und verfahren zur herstellung.
ES8700933A1 (es) Un metodo para preparar esterol-liposomas
GB1440386A (en) Tratment of mosaic bone fractures of the bone and periosteum in non-human animals
ES8600498A1 (es) Un metodo de liofilizar una solucion acuosa de una globulina insoluble en frio
KR880013572A (ko) 인슐린 및 인슐린 유도체의 혼합결정체, 이의 제조방법, 이를 함유하는 약제 및 이의 용도
ES2082110T3 (es) Metodo para preparar un suplemento alimenticio acuoso para ganado y suplemento alimenticio acuoso preparado de esta manera.
SU1433390A3 (ru) Способ получени антибактериальной соли щелочного металла 7 @ -дифторметил-тиоацефамидо-7 @ -метокси-3-[1-(2-гидроксиалкил)-1Н-тетразол-5-ил]тиометил-1-детиа-1-окса-3-цефем-4-карбоновой кислоты
ATE25807T1 (de) Kochsalzersatz-zusammensetzung.
BR8601513A (pt) Processo para a preservacao de bacterias produtoras de acidos,suspensao de bacterias assim preparada e composicao
ES2056059T3 (es) Un metodo para preparar cefadroxil monohidrato cristalino.
ES8504700A1 (es) Un procedimiento para la preparacion de cefoperazona sodica altamente cristalina
KR860006982A (ko) 안정한 감마 인터페론 제형의 제조방법
DK600289D0 (da) Afkoelingsvaeske for fisk
ES8301626A1 (es) Un procedimiento mejorado para producir un preparado antimicrobiano de d-7(&-(4-hidroxi-6-metilnicotinamido)-4-hidroxi- fenilacetamido)-3-(1-metiltetrazol-5-il) tiometil-a3-cefem-4-carboxilato de sodio.
ES2183816T3 (es) Inyeccion para tratar tejidos alterados lesionados, procedimiento para su produccion, y su utilizacion.
BR9900795A (pt) Processo para a preservação de produtos alimentìcios.
CO4600664A1 (es) Composicion de levadura y proceso para introduccion de leva- dura y los productos asi obtenidos
US2266992A (en) Therapeutic composition
SU959786A1 (ru) Способ консервировани цельной крови
Koh Intestinal absorption of heparin
SU1355212A1 (ru) Способ консервировани спермы человека

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 367090

Country of ref document: ES